Stocks & Investing
Mon, September 23, 2024
[ Mon, Sep 23rd 2024
] - WOPRAI
Mon, September 16, 2024
[ Mon, Sep 16th 2024
] - WOPRAI
Wed, September 4, 2024
[ Wed, Sep 04th 2024
] - WOPRAI
[ Wed, Sep 04th 2024
] - WOPRAI
Mon, June 24, 2024
[ Mon, Jun 24th 2024
] - WOPRAI
Fri, June 21, 2024
[ Fri, Jun 21st 2024
] - WOPRAI
Fri, May 10, 2024
[ Fri, May 10th 2024
] - WOPRAI
Wed, May 8, 2024
[ Wed, May 08th 2024
] - WOPRAI
Thu, March 28, 2024
[ Thu, Mar 28th 2024
] - WOPRAI
Tue, March 12, 2024
[ Tue, Mar 12th 2024
] - WOPRAI
Thu, December 21, 2023
[ Thu, Dec 21st 2023
] - WOPRAI
Thu, December 14, 2023
[ Thu, Dec 14th 2023
] - WOPRAI
Tue, December 5, 2023
[ Tue, Dec 05th 2023
] - WOPRAI
Thu, July 13, 2023
[ Thu, Jul 13th 2023
] - WOPRAI
Fri, May 26, 2023
[ Fri, May 26th 2023
] - WOPRAI
Mon, May 22, 2023
[ Mon, May 22nd 2023
] - WOPRAI
Mon, May 15, 2023
[ Mon, May 15th 2023
] - WOPRAI
Wed, May 10, 2023
[ Wed, May 10th 2023
] - WOPRAI
Mon, April 24, 2023
[ Mon, Apr 24th 2023
] - WOPRAI
Fri, April 14, 2023
[ Fri, Apr 14th 2023
] - WOPRAI
Tue, April 4, 2023
[ Tue, Apr 04th 2023
] - WOPRAI
Tue, March 28, 2023
[ Tue, Mar 28th 2023
] - WOPRAI
Mon, March 20, 2023
[ Mon, Mar 20th 2023
] - WOPRAI
Fri, March 17, 2023
[ Fri, Mar 17th 2023
] - WOPRAI
Tue, March 14, 2023
[ Tue, Mar 14th 2023
] - WOPRAI
Tue, February 28, 2023
[ Tue, Feb 28th 2023
] - WOPRAI
Thu, December 15, 2022
[ Thu, Dec 15th 2022
] - WOPRAI
Tue, November 29, 2022
[ Tue, Nov 29th 2022
] - WOPRAI
Thu, November 17, 2022
[ Thu, Nov 17th 2022
] - WOPRAI
Wed, November 9, 2022
[ Wed, Nov 09th 2022
] - WOPRAI
Tazeen Ahmad Maintained (ASND) at Strong Buy with Increased Target to $191 on, Sep 23rd, 2024
Tazeen Ahmad of B of A Securities, Maintained "Ascendis Pharma A/S" (ASND) at Strong Buy with Increased Target from $175 to $191 on, Sep 23rd, 2024.
Tazeen has made no other calls on ASND in the last 4 months.
There are 10 other peers that have a rating on ASND. Out of the 10 peers that are also analyzing ASND, 0 agree with Tazeen's Rating of Hold.
These are the ratings of the 10 analyists that currently disagree with Tazeen
- David Lebowitz of "Citigroup" Maintained at Strong Buy with Increased Target to $207 on, Tuesday, September 17th, 2024
- Derek Archila of "Wells Fargo" Maintained at Buy with Increased Target to $289 on, Tuesday, September 17th, 2024
- Josh Schimmer of "Evercore ISI Group" Maintained at Buy with Increased Target to $205 on, Tuesday, September 17th, 2024
- Leland Gershell of "Oppenheimer" Reiterated at Buy with Increased Target to $190 on, Tuesday, September 17th, 2024
- Paul Choi of "Goldman Sachs" Maintained at Strong Buy with Increased Target to $200 on, Tuesday, September 17th, 2024
- Li Watsek of "Cantor Fitzgerald" Reiterated at Buy and Held Target at $170 on, Monday, September 16th, 2024
- Yaron Werber of "TD Cowen" Maintained at Strong Buy with Decreased Target to $157 on, Wednesday, September 4th, 2024
- Jessica Fye of "JP Morgan" Maintained at Buy with Decreased Target to $165 on, Wednesday, September 4th, 2024
- Kelly Shi of "Jefferies" Maintained at Strong Buy with Increased Target to $196 on, Tuesday, August 13th, 2024
- Alex Thompson of "Stifel" Initiated at Strong Buy and Held Target at $200 on, Friday, May 31st, 2024
